Search Results 2011-2020 of 16193 for Epilepsy (Partial Onset)

1. Effectiveness and Safety of Pembrolizumab for Participants with Resectable Stage IIB or IIIA Non-small Cell Lung Cancer - Mayo Clinic

   About this study. This trial will evaluate the safety and effectiveness of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant ...

2. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... epilepsy, Brain tumor-associated epilepsy. Show more areas of focus for Kaisorn L. Chaichana, M.D.. Brent A. Chang, M.D.. Otolaryngologist.

3. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

   Multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of abatacept to achieve sustained glucocorticoid-free remission in ...

4. A Study to Evaluate 9-ING-41 As a Single Agent or in Combination with Ruxolitinib in Myelofibrosis Patients - Mayo Clinic

   ... duration to confer an optimal therapeutic outcome. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

5. Migraine Clinical Trials - Mayo Clinic Research

   The purpose of this study is to predict migraine headache onset from changes in speech in people who have a history of migraines. ... onset premonitory changes ...

6. Anxiety Disorders Clinical Trials

   ... epilepsy Rochester, MN. This study aims to assess the level of anxiety and depression in children with epilepsy and compare to the level of anxiety and ...

7. Endocrinology Clinical Trials - Medical Professionals

   Rochester, Minn. The primary purpose of this study is to determine pre-surgical and post-surgical predictors of the duration and severity of glucocorticoid ...

8. TRC-PAD Program: In-Clinic Trial-Ready Cohort

   ... seizure disorder, subdural hematoma, multiple sclerosis, or history of significant head trauma followed by persistent neurologic deficits or known ...

9. A Study to Evaluate CPI-006 with Standard of Care vs. Placebo with Standard of Care in Mild-to-moderately Symptomatic Hospitalized Covid-19 Patients (Enrolling by Invitation Only) - Mayo Clinic

   Covid-19 illness of any duration of symptoms. ... Participant must understand and agree to comply with planned study procedures for the duration of the study.

10. Health Topics - Mayo Clinic News Network

    Note: November is National Epilepsy Awareness Month. Using deep brain stimulation techniques, neuroscientists at Mayo Clinic are looking for early signals ...